In regulated categories, distribution is the strategy

Restricted marketing pushes power downstream

Cannabinoid brands operate without the standard growth toolkit. Meta and Google will not run the ads. Mainstream payment providers periodically reclassify CBD as high risk and freeze or offboard accounts, sometimes mid-quarter, which is a cash-flow event as much as a marketing one. Health and wellbeing claims that would sell the product are the exact claims you are not allowed to make. Organic reach in the category is throttled.

So what remains is availability: being physically and digitally where the customer already is, with someone knowledgeable standing next to the product. That shifts power to whoever owns access — specialist retail and growshops, pharmacy wholesalers, distributors, marketplaces. Running retail on the buying side of that table, the pattern was consistent: the brands that won shelf were rarely the best formulated ones. They were the ones that made the buyer's job easy and then stayed on the shelf.

In cannabinoids, 'can they distribute' is a compliance question

In most categories, distributor diligence is commercial. In this one it is commercial and regulatory at the same time, and the regulatory half is what kills launches. A distributor with excellent accounts is still useless to you if they cannot hold and move your specific SKU legally in that country.

Concretely: ingestible CBD in the EU still sits under Novel Food, and whether a partner will stock an unauthorised ingestible varies by country and by how conservative their own customers are. THC thresholds differ — a batch that ships fine into one member state fails inspection in another, and the difference is decimal points on a certificate of analysis. Labelling, language and warning requirements are national, so 'we'll relabel locally' is a real cost line, not a footnote. Ask whether the partner has ever had a batch held, and what happened next. The answer tells you more than their revenue figure.

• Do they already stock cannabinoid SKUs, or only adjacent products like vapes, smoking accessories and grow equipment
• Which lab do they accept COAs from, and will they re-test on arrival at your cost
• Can they hold ingestibles, or only cosmetics, flower-adjacent and non-ingestible formats
• Do they handle national labelling and language requirements in-house
• Have they lost a listing or had stock detained in the category before — and what did they learn

Choose partners on capability, not enthusiasm

The most common expansion mistake is signing the first partner who says yes. Enthusiasm is abundant and cheap in emerging categories; capability is rare. A partner who is excited but has no compliant storage, no existing accounts in your channel and no sales team will consume a year of your time and produce a pallet of returns.

A pattern worth naming, because it repeats: companies spend months negotiating a distribution agreement and only discover after signature that the partner has no meaningful sales infrastructure in the target market — one person, a spreadsheet of prospects, and an intention to hire. Nothing in the contract prevents this. The only defence is verification before signature: named accounts you can call, an order history in the category, and a walk through their warehouse.

• Which accounts do they already supply, and can you verify it independently
• How many salespeople actually carry the bag, and what else is in it
• Payment behaviour, stock-holding capacity and their own credit terms upstream
• Whether you are strategic to them or a line item added to look complete

Exclusivity is a price, not a gift

Distributors ask for exclusivity early, because it costs them nothing and protects them from competition. If you grant it, price it: minimum volumes, defined listings within a defined window, marketing commitments, and a clean exit if targets are missed. Open-ended exclusivity with no performance condition is the fastest way to lock yourself out of a market you have not yet entered.

In cannabinoids there is a second clause worth adding: what happens when the rules move. If a format becomes restricted, a THC limit is revised, or a channel stops listing the category, both sides need a defined route to renegotiate rather than a dead agreement neither party can exit.

Design the margin stack before the first order

Work backwards from the shelf price. Deduct retail margin, distributor margin, logistics, per-batch lab testing, national relabelling, compliance time and returns. What is left is your real ex-works price. If that number does not support your cost base, no amount of negotiation later will fix it, because every participant defends their percentage.

Two lines get underestimated in this category specifically. Testing is per batch, not per launch, so small production runs carry a disproportionate compliance cost per unit — the maths punishes cautious first orders. And customer acquisition costs more when paid channels are closed to you, which means the channel itself has to do work that advertising would do elsewhere: sales training, staff incentives where permitted, point-of-sale material, and your own team's time in-store. Distribution is not passive income. It is an operating commitment.

One market properly, before three markets badly

Expansion fails more often through dilution than through choosing the wrong country. Three simultaneous launches usually means three under-supported partners, three sets of national labelling and testing work, and no reference case anywhere. One market executed properly produces something far more valuable: proof, a repeatable playbook, and a reference every future distributor will ask for.

The compounding effect is real. Once one market is running with clean documentation, a COA pack a buyer accepts without argument and artwork that already satisfies one national labelling regime, the second market is a variation rather than a rebuild.

What this means in practice

Treat partner selection with the seriousness you would give a hire or an acquisition. Diligence them commercially and regulatorily, structure the agreement around performance, and stay close to the account after signature — the first six months decide whether you are a listed brand or a stored pallet.

In regulated categories the company that controls its route to market controls its outcome. The one that outsources that decision to whoever answered the email first has, in effect, outsourced its strategy.